HEALTH

GSK Consumer Healthcare applauds FDA’s workshop on NRT products

BY Michael Johnsen

PARSIPPANY, N.J. GlaxoSmithKline Consumer Healthcare on Thursday commended the Food and Drug Administration for holding a scientific workshop this week that focused on the risks and benefits associated with the long-term use of nicotine-replacement therapy products.

 

GSK, the manufacturer of smoking-cessation products NicoDerm and Nicorette, suggested the workshop is a first step in supporting language in the 2009 Family Smoking Prevention and Tobacco Control Act, which called upon the FDA to "consider approving the extended use of nicotine-replacement products — such as nicotine patches, nicotine gum and nicotine lozenge — for the treatment of tobacco dependence."

 

 

As a result of the FDA’s review of long-term use, GSK has submitted a statement into the FDA public docket on its position regarding the long-term use of NRT. GSK believes that using NRT products to quit smoking is far safer than continuing to smoke. NRT products offer a step-down therapy that doubles a smoker’s chances of quitting versus attempting to quit smoking “cold turkey.” Additionally, several other countries already encourage the use of NRT products for longer durations to keep people tobacco-free.

 

 

Smoking is the No. 1 preventable cause of disease and death in the United States. More than 46 million Americans smoke. Research indicated about 70% of smokers want to quit at any given time, but the success rates remain suboptimal. Tobacco use causes more than 400,000 deaths in the United States each year, and approximately 8.6 million Americans have chronic illnesses related to smoking.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Walgreens continues vitamin D giveaway program with Aetna, United Way

BY Allison Cerra

COLUMBIA , S.C. (May 27) One of the nation’s largest drug store chains has teamed up with a healthcare benefits company and a community solutions provider to raise awareness of the need for adequate vitamin D intake.

Walgreens, Aetna and United Way of the Midlands are continuing their efforts through a vitamin D giveaway program extension, which initially was kicked off earlier this year. The vitamin D awareness efforts will donate more than 25,000 samples, the companies said.

“We are pleased to continue our participation in this program to drive awareness around a health concern that’s seldom discussed in many communities,” said Richard Ashworth, Walgreens market VP. “Our goal is for more people to be informed that supporting a proper diet and healthy lifestyle with a vitamin D supplement is a simple step that can have long-term health benefits.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Study: Fish oil may aid dental health

BY Michael Johnsen

ST. LOUIS, Mo. Supplementing with fish oils could help improve gum health, according to research published in the November issue of the Journal of the American Dietetic Association. Researchers from Harvard Medical School and Harvard School of Public Health found that dietary intake of polyunsaturated fatty acids like fish oil, known to have anti-inflammatory properties, shows promise for the effective treatment and prevention of periodontitis, otherwise known as gum disease.

"We found that n-3 fatty acid intake, particularly docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), are inversely associated with periodontitis in the U.S. population," said researcher Asghar Naqvi. "To date, the treatment of periodontitis has primarily involved mechanical cleaning and local antibiotic application. Thus, a dietary therapy, if effective, might be a less expensive and safer method for the prevention and treatment of periodontitis. Given the evidence indicating a role for n-3 fatty acids in other chronic inflammatory conditions, it is possible that treating periodontitis with n-3 fatty acids could have the added benefit of preventing other chronic diseases associated with inflammation, including stroke as well."

 

The study involved more than 9,000 adults who participated in NHANES between 1999 and 2004 who had received dental examinations. Dietary DHA, EPA and LNA intake were estimated from 24-hour food recall interviews, and data regarding supplementary use of PUFAs were captured as well. The NHANES study also collected extensive demographic, ethnic, educational and socioeconomic data, allowing the researchers to take other factors into consideration that might obscure the results.

 

 

The prevalence of periodontitis in the study sample was 8.2%. There was an approximately 20% reduction in periodontitis prevalence in those subjects who consumed the highest amount of dietary DHA. The reduction correlated with EPA was smaller, while the correlation to LNA was not statistically significant.

 

 

Foods that contain significant amounts of polyunsaturated fats include fatty fish like salmon, as well as peanut butter, margarine and nuts.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES